| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| GALD.SW - | BUY | 4,545 @ CHF 118.538 | CHF 538,755 | The ETF bought 4545 new shares of GALD.SW (). The shares were bought for an average price of 118.538 compared to the previous average buy price of 100.889. This is 17.5% higher than average price of previous purchases of GALD.SW. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 118.6 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 118.6. The average price that BIM.PA shares were previous bought at was EUR 109.561. The current market price is 8.3% higher than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 8,027 (USD $9,113) compared to the previous valuation of BioMerieux however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 300.895 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 300.895. The average price that RO.SW shares were previous bought at was CHF 302.705. The current market price is -0.6% lower than average price they were purchased at. The value of the holding in RO.SW has increased by CHF 8,395 (USD $10,210) compared to the previous valuation of however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 50.4 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 50.4. The average price that FME.DE shares were previous bought at was EUR 46.5101. The current market price is 8.4% higher than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 32,251 (USD $36,616) compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 58.76 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 58.76. The average price that ERF.PA shares were previous bought at was EUR 50.2178. The current market price is 17.0% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 913 (USD $1,037) compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 205 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 205. The average price that SRT3.DE shares were previous bought at was EUR 222.541. The current market price is -7.9% lower than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 61,320 (USD $69,619) compared to the previous valuation of Sartorius AG |
| SOBI.ST - | HOLD | 0 @ SEK 27.9726 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 27.9726. The average price that SOBI.ST shares were previous bought at was SEK 26.8958. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 82,595 (USD $8,624) compared to the previous valuation of however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 189.5 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 189.5. The average price that DIM.PA shares were previous bought at was EUR 190.276. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 51,178 (USD $58,104) compared to the previous valuation of Sartorius Stedim Biotech |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 52.8 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 52.8. The average price that REC.MI shares were previous bought at was EUR 52.4923. The current market price is 0.6% higher than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 60.15 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 60.15. The average price that ORNBV.HE shares were previous bought at was EUR 49.2948. The current market price is 22.0% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 16,702 (USD $18,962) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 12.7588 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 12.7588. The average price that SN.L shares were previous bought at was GBP 12.757. The current market price is 0.0% higher than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 1,619 (USD $2,180) compared to the previous valuation of Smith & Nephew PLC |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 103.7 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 103.7. The average price that IPN.PA shares were previous bought at was EUR 107.376. The current market price is -3.4% lower than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Ipsen SA |
| HIK.L - | HOLD | 0 @ GBP 25.4584 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 25.4584. The average price that HIK.L shares were previous bought at was GBP 24.3915. The current market price is 4.4% higher than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 2,435 (USD $3,279) compared to the previous valuation of however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| DEMANT.CO - | HOLD | 0 @ DKK 33.7239 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 33.7239. The average price that DEMANT.CO shares were previous bought at was DKK 34.2927. The current market price is -1.7% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 24,044 (USD $3,659) compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 9.624 | EUR 0 | |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 90.4 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 90.4. The average price that DIA.MI shares were previous bought at was EUR 66.4761. The current market price is 36.0% higher than average price they were purchased at. The value of the holding in DIA.MI has fallen by EUR 8,392 (USD $9,528) compared to the previous valuation of DiaSorin SpA |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 63.668 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 63.668. The average price that NOVO-B.CO shares were previous bought at was DKK 66.7595. The current market price is -4.6% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 3,542,984 (USD $539,193) compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 83.9881 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 83.9881. The average price that COLO-B.CO shares were previous bought at was DKK 94.804. The current market price is -11.4% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 59,335 (USD $9,030) compared to the previous valuation of |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 39.455 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 39.455. The average price that QIA.DE shares were previous bought at was EUR 37.1265. The current market price is 6.3% higher than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 24,758 (USD $28,109) compared to the previous valuation of QIAGEN NV |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.91152 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.91152. The average price that HLN.L shares were previous bought at was GBP 4.69317. The current market price is 4.7% higher than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 17,916 (USD $24,128) compared to the previous valuation of Haleon PLC |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 25.14 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 25.14. The average price that BAYN.DE shares were previous bought at was EUR 21.5812. The current market price is 16.5% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 153,449 (USD $174,215) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 101.812 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 101.812. The average price that NOVN.SW shares were previous bought at was CHF 97.6741. The current market price is 4.2% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 728,174 (USD $885,566) compared to the previous valuation of however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 125.324 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 125.324. The average price that AZN.L shares were previous bought at was GBP 128.59. The current market price is -2.5% lower than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 1,206,333 (USD $1,624,603) compared to the previous valuation of AstraZeneca PLC |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 85.91 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 85.91. The average price that SAN.PA shares were previous bought at was EUR 96.5074. The current market price is -11.0% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 689,349 (USD $782,640) compared to the previous valuation of Sanofi SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 17.9797 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 17.9797. The average price that GSK.L shares were previous bought at was GBP 16.6662. The current market price is 7.9% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 124,146 (USD $167,191) compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 245.1 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 245.1. The average price that EL.PA shares were previous bought at was EUR 249.393. The current market price is -1.7% lower than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 45,876 (USD $52,084) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 608.858 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 608.858. The average price that LONN.SW shares were previous bought at was CHF 582.506. The current market price is 4.5% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 40,022 (USD $48,673) compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 74.6563 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 74.6563. The average price that ALC.SW shares were previous bought at was CHF 82.2971. The current market price is -9.3% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 221,247 (USD $269,069) compared to the previous valuation of |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 505.6 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 505.6. The average price that ARGX.BR shares were previous bought at was EUR 557.401. The current market price is -9.3% lower than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 18,838 (USD $21,387) compared to the previous valuation of Argenx SE |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 162 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 162. The average price that UCB.BR shares were previous bought at was EUR 173.202. The current market price is -6.5% lower than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 102,394 (USD $116,251) compared to the previous valuation of UCB SA however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 283.441 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 283.441. The average price that ROG.SW shares were previous bought at was CHF 286.208. The current market price is -1.0% lower than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 332,498 (USD $404,366) compared to the previous valuation of |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 19.88 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 19.88. The average price that PHIA.AS shares were previous bought at was EUR 23.6773. The current market price is -16.0% lower than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 113,121 (USD $128,430) compared to the previous valuation of Koninklijke Philips NV |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 114.75 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 114.75. The average price that MRK.DE shares were previous bought at was EUR 132.284. The current market price is -13.3% lower than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 37,383 (USD $42,442) compared to the previous valuation of Merck KGaA |
| SDZ.SW - | HOLD | 0 @ CHF 44.7381 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 44.7381. The average price that SDZ.SW shares were previous bought at was CHF 39.8234. The current market price is 12.3% higher than average price they were purchased at. The value of the holding in SDZ.SW has fallen by CHF 757 (USD $921) compared to the previous valuation of |
| SOON.SW - | HOLD | 0 @ CHF 272.091 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 272.091. The average price that SOON.SW shares were previous bought at was CHF 295.13. The current market price is -7.8% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 80,285 (USD $97,638) compared to the previous valuation of |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 45.79 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 45.79. The average price that SHL.DE shares were previous bought at was EUR 48.381. The current market price is -5.4% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 103,102 (USD $117,055) compared to the previous valuation of Siemens Healthineers AG |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 44.03 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 44.03. The average price that FRE.DE shares were previous bought at was EUR 37.2287. The current market price is 18.3% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 138,477 (USD $157,217) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 190.803 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 190.803. The average price that GMAB.CO shares were previous bought at was DKK 190.727. The current market price is 0.0% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 145,149 (USD $22,090) compared to the previous valuation of however if the holding was sold on 2025-06-02 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 111.631 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 111.631. The average price that STMN.SW shares were previous bought at was CHF 119.13. The current market price is -6.3% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 66,264 (USD $80,587) compared to the previous valuation of |